ROP — Roper Technologies
Price when we picked it (Apr 6, 2026)
$360.46
Target: $478.00 (+32.6%)
P/E Ratio
25.4
P/E Forward
15.4
Dividend
0.95%
Market Cap
$38.8B
EPS
$20
Consensus
Buy
What they do
Roper Technologies is a diversified technology company that acquires and operates leading niche-specific software businesses — software for lawyers (Aderant), government contractors (Deltek), freight (DAT), labs (Clinisys), and more. It generates over 85% of recurring revenue.
It operates through three segments: Application Software (~58% revenue), Network Software (~21%), and Technology Enabled Products (~21%). Each portfolio company — from Vertafore in insurance tech to Foundry in Hollywood visual effects — holds the #1 or #2 position in its niche.
In 2025, it spent $3.3B on high-quality acquisitions: CentralReach ($1.85B, ABA therapy software with over 20% growth) and Subsplash ($800M, digital platform for churches).
Why we like it
Roper is a top-tier growth machine temporarily on sale. With a cash coming in margin of 31% ($2.47B), how much they keep per sale at 69.5%, and over 85% recurring revenue — these are first-class SaaS company metrics. It fell -44% due to temporary challenges: DOGE cuts affecting Deltek (government) and freight recession affecting DAT.
At $360, ROP trades at a price vs. profit forward of 15.4x — half of its historical pricing (~30x). With over $6B in acquisition capacity, 33 years of dividend growth, and a pipeline of 25+ AI products deployed, the growth engine remains intact.
Analysts say Buy with an average target of ~$478 (33% upside). The stock trades near Barclays' low target ($380), offering a safety margin.
Key Risk
The main risk is how they manage their money — Roper's model relies on buying businesses at attractive prices. With $9.5B in total debt (how big their debt is vs. earnings at 2.9x) and a return on invested capital of ~5-6% due to recent acquisition goodwill, the company must prove that CentralReach and Subsplash generate incremental returns.
Additional risks: DOGE cuts pressure Deltek's federal customer base more than expected; prolonged freight recession affects DAT; and if vertical software acquisition prices rise, the acquisition growth engine slows.
This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.
Vectorial Data picked ROP on Apr 6, 2026 at $360.46.
Full Research
Roper Technologies (ROP) — Complete Research
Price: $360.46 | P/E Forward: 15.4 | Div Yield: 0.95% | Market Cap: $38.8B
What is Roper Technologies?
Roper Technologies is the "Berkshire Hathaway of software" — a company that acquires and operates leading niche-specific software businesses. With $7.9B in revenue and over 85% recurring revenue, Roper has completed one of the most notable corporate transformations: from industrial conglomerate to pure software growth company.
Portfolio Companies
Application Software (~58% revenue)
| Company | Niche | Position |
|---|---|---|
| Vertafore | Insurance tech | #1, 50+ years in the market |
| Deltek | Software for government contractors | Leader, 23,000+ orgs in 80+ countries |
| Aderant | Software for law firms | 77 of the top 100 Global Law Firms |
| CentralReach | ABA therapy (autism) | Leader, 200,000+ professionals |
| Strata | Hospital finance | Leader in healthcare analytics |
| Frontline | K-12 administration | Leading school software |
Network Software (~21% revenue)
| Company | Niche | Position |
|---|---|---|
| DAT Solutions | Freight marketplace | #1 in North America |
| ConstructConnect | Construction bidding | Leading pre-construction network |
| iPipeline | Life insurance distribution | Dominant platform |
| Foundry (Nuke) | Film/TV visual effects | Used in Marvel, Star Wars |
| Subsplash | Church digital engagement | Leader in $2.5B TAM |
Technology Enabled Products (~21% revenue)
| Company | Niche | Position |
|---|---|---|
| Neptune | Smart water meters | Leader in smart water metering |
| Verathon | Medical devices | GlideScope (video laryngoscopes) |
| NDI | 3D surgical measurement | Precision surgical navigation |
Key Numbers 2025
| Metric | Value |
|---|---|
| Revenue | $7.9B (+12.3% YoY) |
| Organic Growth | +5% |
| Gross Margin | 69.5% (+120bps YoY) |
| EBITDA | $3.14B (39.8% margin) |
| Free Cash Flow | $2.47B (31.2% FCF margin) |
| EPS | $20.00 (+9% YoY) |
| Recurring Revenue | 85%+ |
| Employees | 18,000+ |
Dividend — 33 Years of Consecutive Growth
- Annual Dividend: $3.64/share ($0.91 quarterly)
- Yield: 0.95%
- Payout Ratio: ~22% (ample growth space)
- Growth: 33 consecutive years
- 5-Year CAGR: ~10% annually
Why We Rebuy ROP
ROP at $360 is a top-tier growth company temporarily on sale. The challenges are cyclical (DOGE/Deltek, freight/DAT), not structural. The growth engine remains intact:
- $3.3B deployed in 2025 in CentralReach (20%+ growth) and Subsplash (high-teens growth)
- 25+ AI products deployed across the portfolio (HerculesAI for legal, Spectrum AI for therapy)
- $6B+ in future M&A capacity
- 2026 Guidance: Revenue ~8% growth, EPS $21.30-$21.55
- Buyback: $500M program signals management conviction
Analyst Analysis
| Metric | Value |
|---|---|
| Consensus | Buy |
| Analysts | 14-18 |
| Average Target | $478 |
| Target Range | $365 - $625 |
| Upside | +32.6% |
Main Risks
- Capital allocation — $34.6B goodwill in assets; ROIC of 5-6% due to recent acquisitions
- DOGE — Government spending cuts pressure Deltek
- Freight recession — DAT affected by low transport cycle
- Leverage — $9.5B total debt, 2.9x net debt/EBITDA
- M&A multiples — If vertical software gets pricier, the acquisition engine slows
Current Valuation
| Metric | Value |
|---|---|
| Price | $360.46 |
| P/E Forward | 15.4x (vs historical ~28-30x) |
| Div Yield | 0.95% |
| FCF Yield | ~6.4% |
| 52-Week High | ~$640 |
| Current Drawdown | ~-44% from peak |
Conclusion
ROP at $360 is a chance to rebuy the most disciplined software growth company in the market at half its historical pricing. The 31% cash coming in margin, over 85% recurring revenue, and 33 years of dividend growth provide downside protection, while the upside comes from re-rating when cyclical challenges pass. With 33% upside according to analysts plus the dividend, we are accumulating position.
Research date: Apr 6, 2026 | Next review: Oct 2026
This is not financial advice.
This is not financial advice. Consult a certified financial advisor.
The author may hold positions in the securities discussed.
Past performance does not guarantee future results.